EvoGenix To List On ASX In August; Will Open Its IPO Within A Week

October 19, 2005 |

1 min read

Antibody therapeutics company EvoGenix will open its initial public offering within a week and list on the ASX in early to mid-August, with the aim of raising AUD$9 million.

IPO

MORE ON THIS TOPIC

Hand collage holding dollar paper money isolated on yellow background. Using cash to buy concept. Halftone effect in pop art style illustration.

Breast cancer

Novartis Buys Breast Cancer Drug for $2B to Keep Up With Myriad Rivals

March 20, 2026

·

2 min read

·

Tristan Manalac

Big fish eats small, takeover of the company. Art collage.

Mergers & acquisitions

In Tight Deal Environment, Pharma May Need To Think Big

March 18, 2026

·

5 min read

·

Annalee Armstrong

Confrontation and opposite opinions concept. Business people hands pulling rope in opposite directions in office showing power and leadership vector illustration

Mergers & acquisitions

Pharma Is Ravenous for M&A Action but Late-Stage Supply Dwindles

March 11, 2026

·

5 min read

·

Annalee Armstrong

Brain tumor medical poster. Cancer, metastasis or benign in the human head or in the nerves, pituitary gland, pineal gland, and membranes that cover the surface of the brain 3D vector illustration

Mergers & acquisitions

Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy

March 6, 2026

·

1 min read

·

Annalee Armstrong